nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—CYP2D6—Niacin—coronary artery disease	0.0563	0.173	CbGbCtD
Methylphenidate—CYP2D6—Timolol—coronary artery disease	0.0523	0.161	CbGbCtD
Methylphenidate—CYP2D6—Captopril—coronary artery disease	0.0461	0.141	CbGbCtD
Methylphenidate—CYP2D6—Simvastatin—coronary artery disease	0.0445	0.136	CbGbCtD
Methylphenidate—CYP2D6—Lovastatin—coronary artery disease	0.0435	0.134	CbGbCtD
Methylphenidate—CYP2D6—Pravastatin—coronary artery disease	0.0435	0.134	CbGbCtD
Methylphenidate—CYP2D6—Atorvastatin—coronary artery disease	0.0397	0.122	CbGbCtD
Methylphenidate—SLC6A4—NRF2 pathway—GSTP1—coronary artery disease	0.000225	0.00235	CbGpPWpGaD
Methylphenidate—SLC6A4—NRF2 pathway—TGFBR2—coronary artery disease	0.000225	0.00235	CbGpPWpGaD
Methylphenidate—SLC6A4—NRF2 pathway—HMOX1—coronary artery disease	0.000222	0.00231	CbGpPWpGaD
Methylphenidate—CYP2D6—Melatonin metabolism and effects—APOE—coronary artery disease	0.000222	0.00231	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—GGT1—coronary artery disease	0.000216	0.00225	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—ADIPOQ—coronary artery disease	0.000213	0.00221	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—PPARGC1A—coronary artery disease	0.000212	0.00221	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—CFTR—coronary artery disease	0.000211	0.00219	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	0.000211	0.00219	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—FXYD1—coronary artery disease	0.00021	0.00218	CbGpPWpGaD
Methylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC8A1—coronary artery disease	0.000209	0.00217	CbGpPWpGaD
Methylphenidate—SLC6A3—SLC-mediated transmembrane transport—HK1—coronary artery disease	0.000209	0.00217	CbGpPWpGaD
Methylphenidate—SLC6A4—NRF2 pathway—HGF—coronary artery disease	0.000207	0.00216	CbGpPWpGaD
Methylphenidate—SLC6A4—NRF2 pathway—GSTM1—coronary artery disease	0.000207	0.00216	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—HSPA1A—coronary artery disease	0.000204	0.00213	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—HTR7—coronary artery disease	0.000203	0.00211	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—ALDH2—coronary artery disease	0.000203	0.00211	CbGpPWpGaD
Methylphenidate—SLC6A3—Monoamine Transport—TNF—coronary artery disease	0.000202	0.00211	CbGpPWpGaD
Methylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—coronary artery disease	0.000202	0.0021	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	0.000201	0.00209	CbGpPWpGaD
Methylphenidate—SLC6A4—NRF2 pathway—AGER—coronary artery disease	0.0002	0.00208	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL1A—coronary artery disease	0.000198	0.00206	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL10—coronary artery disease	0.000197	0.00205	CbGpPWpGaD
Methylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C19—coronary artery disease	0.000196	0.00204	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—TGFBR2—coronary artery disease	0.000194	0.00202	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—GSTP1—coronary artery disease	0.000194	0.00202	CbGpPWpGaD
Methylphenidate—CYP2D6—Melatonin metabolism and effects—GSK3B—coronary artery disease	0.000192	0.002	CbGpPWpGaD
Methylphenidate—CYP2D6—Biological oxidations—GSTM2—coronary artery disease	0.000192	0.00199	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—HMOX1—coronary artery disease	0.000191	0.00199	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—GGT1—coronary artery disease	0.000191	0.00199	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—MEF2C—coronary artery disease	0.000191	0.00199	CbGpPWpGaD
Methylphenidate—CYP2D6—Metapathway biotransformation—GSTM2—coronary artery disease	0.000189	0.00197	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	0.000187	0.00194	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—CFTR—coronary artery disease	0.000187	0.00194	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—CAMK2D—coronary artery disease	0.000185	0.00193	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—PLCB3—coronary artery disease	0.000184	0.00192	CbGpPWpGaD
Methylphenidate—CYP2D6—Biological oxidations—SULT1E1—coronary artery disease	0.000182	0.00189	CbGpPWpGaD
Methylphenidate—CYP2D6—Metapathway biotransformation—SULT1E1—coronary artery disease	0.000179	0.00186	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	0.000178	0.00185	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—GSTM1—coronary artery disease	0.000178	0.00185	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—HGF—coronary artery disease	0.000178	0.00185	CbGpPWpGaD
Methylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC9A1—coronary artery disease	0.000176	0.00184	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—HTR2A—coronary artery disease	0.000174	0.00181	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—PPARGC1A—coronary artery disease	0.000173	0.0018	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—AGER—coronary artery disease	0.000172	0.00179	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—GSTP1—coronary artery disease	0.000172	0.00179	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—TGFBR2—coronary artery disease	0.000172	0.00179	CbGpPWpGaD
Methylphenidate—CYP2D6—Metapathway biotransformation—AKR1B1—coronary artery disease	0.000171	0.00178	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—HMOX1—coronary artery disease	0.000169	0.00176	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—RYR2—coronary artery disease	0.000169	0.00175	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—COX5B—coronary artery disease	0.000169	0.00175	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—SIRT1—coronary artery disease	0.000167	0.00174	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—HIF1A—coronary artery disease	0.000166	0.00172	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—PLN—coronary artery disease	0.000164	0.00171	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—PLCB1—coronary artery disease	0.000158	0.00165	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—GSTM1—coronary artery disease	0.000158	0.00164	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—HGF—coronary artery disease	0.000158	0.00164	CbGpPWpGaD
Methylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC9A1—coronary artery disease	0.000156	0.00163	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—ALDH2—coronary artery disease	0.000155	0.00162	CbGpPWpGaD
Methylphenidate—CYP2D6—Biological oxidations—GCLM—coronary artery disease	0.000154	0.00161	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—HK2—coronary artery disease	0.000152	0.00159	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—AGER—coronary artery disease	0.000152	0.00158	CbGpPWpGaD
Methylphenidate—CYP2D6—Biological oxidations—CYP11B2—coronary artery disease	0.00015	0.00156	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—COX5B—coronary artery disease	0.000149	0.00155	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—RYR2—coronary artery disease	0.000149	0.00155	CbGpPWpGaD
Methylphenidate—CYP2D6—Metapathway biotransformation—CYP11B2—coronary artery disease	0.000148	0.00154	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	0.000146	0.00152	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—ATP4A—coronary artery disease	0.000146	0.00152	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—PLN—coronary artery disease	0.000145	0.00151	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—CAMK2D—coronary artery disease	0.000142	0.00148	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—CREB1—coronary artery disease	0.000139	0.00145	CbGpPWpGaD
Methylphenidate—CYP2D6—Biological oxidations—SULT1A1—coronary artery disease	0.000136	0.00142	CbGpPWpGaD
Methylphenidate—CYP2D6—Metapathway biotransformation—GPX2—coronary artery disease	0.000136	0.00141	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL6R—coronary artery disease	0.000135	0.00141	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—HK2—coronary artery disease	0.000135	0.00141	CbGpPWpGaD
Methylphenidate—CYP2D6—Metapathway biotransformation—GPX4—coronary artery disease	0.000134	0.0014	CbGpPWpGaD
Methylphenidate—CYP2D6—Metapathway biotransformation—SULT1A1—coronary artery disease	0.000134	0.0014	CbGpPWpGaD
Methylphenidate—CYP2D6—Biological oxidations—GSTA1—coronary artery disease	0.000133	0.00138	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—LEP—coronary artery disease	0.000132	0.00137	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	0.00013	0.00135	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	0.00013	0.00135	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—ATP4A—coronary artery disease	0.000129	0.00135	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	0.000129	0.00135	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—NOS2—coronary artery disease	0.000123	0.00128	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—PLCB1—coronary artery disease	0.000121	0.00126	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—ABCG5—coronary artery disease	0.00012	0.00125	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—HK1—coronary artery disease	0.00012	0.00125	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	0.00012	0.00125	CbGpPWpGaD
Methylphenidate—Asthenia—Niacin—coronary artery disease	0.000119	0.000206	CcSEcCtD
Methylphenidate—Fatigue—Losartan—coronary artery disease	0.000119	0.000206	CcSEcCtD
Methylphenidate—Headache—Ezetimibe—coronary artery disease	0.000119	0.000206	CcSEcCtD
Methylphenidate—Malaise—Lisinopril—coronary artery disease	0.000119	0.000205	CcSEcCtD
Methylphenidate—Oedema—Ramipril—coronary artery disease	0.000118	0.000205	CcSEcCtD
Methylphenidate—Anaphylactic shock—Ramipril—coronary artery disease	0.000118	0.000205	CcSEcCtD
Methylphenidate—Vertigo—Lisinopril—coronary artery disease	0.000118	0.000205	CcSEcCtD
Methylphenidate—Dry mouth—Timolol—coronary artery disease	0.000118	0.000204	CcSEcCtD
Methylphenidate—Pain—Losartan—coronary artery disease	0.000118	0.000204	CcSEcCtD
Methylphenidate—Constipation—Losartan—coronary artery disease	0.000118	0.000204	CcSEcCtD
Methylphenidate—Syncope—Lisinopril—coronary artery disease	0.000118	0.000204	CcSEcCtD
Methylphenidate—Vomiting—Eplerenone—coronary artery disease	0.000118	0.000204	CcSEcCtD
Methylphenidate—Feeling abnormal—Furosemide—coronary artery disease	0.000118	0.000204	CcSEcCtD
Methylphenidate—Leukopenia—Lisinopril—coronary artery disease	0.000118	0.000204	CcSEcCtD
Methylphenidate—Nausea—Fenofibrate—coronary artery disease	0.000118	0.000204	CcSEcCtD
Methylphenidate—Pruritus—Niacin—coronary artery disease	0.000118	0.000203	CcSEcCtD
Methylphenidate—Asthenia—Pravastatin—coronary artery disease	0.000117	0.000203	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Furosemide—coronary artery disease	0.000117	0.000203	CcSEcCtD
Methylphenidate—Rash—Eplerenone—coronary artery disease	0.000117	0.000203	CcSEcCtD
Methylphenidate—Urticaria—Perindopril—coronary artery disease	0.000117	0.000203	CcSEcCtD
Methylphenidate—Hypersensitivity—Trandolapril—coronary artery disease	0.000117	0.000203	CcSEcCtD
Methylphenidate—Dermatitis—Eplerenone—coronary artery disease	0.000117	0.000202	CcSEcCtD
Methylphenidate—Diarrhoea—Valsartan—coronary artery disease	0.000117	0.000202	CcSEcCtD
Methylphenidate—Confusional state—Timolol—coronary artery disease	0.000117	0.000202	CcSEcCtD
Methylphenidate—Shock—Ramipril—coronary artery disease	0.000117	0.000202	CcSEcCtD
Methylphenidate—Hypersensitivity—Enalapril—coronary artery disease	0.000117	0.000202	CcSEcCtD
Methylphenidate—Body temperature increased—Perindopril—coronary artery disease	0.000116	0.000202	CcSEcCtD
Methylphenidate—Abdominal pain—Perindopril—coronary artery disease	0.000116	0.000202	CcSEcCtD
Methylphenidate—Palpitations—Lisinopril—coronary artery disease	0.000116	0.000201	CcSEcCtD
Methylphenidate—Diarrhoea—Olmesartan—coronary artery disease	0.000116	0.000201	CcSEcCtD
Methylphenidate—Headache—Eplerenone—coronary artery disease	0.000116	0.000201	CcSEcCtD
Methylphenidate—Nervous system disorder—Ramipril—coronary artery disease	0.000116	0.000201	CcSEcCtD
Methylphenidate—Thrombocytopenia—Ramipril—coronary artery disease	0.000116	0.000201	CcSEcCtD
Methylphenidate—Oedema—Timolol—coronary artery disease	0.000116	0.0002	CcSEcCtD
Methylphenidate—Anaphylactic shock—Timolol—coronary artery disease	0.000116	0.0002	CcSEcCtD
Methylphenidate—Pruritus—Pravastatin—coronary artery disease	0.000116	0.0002	CcSEcCtD
Methylphenidate—Loss of consciousness—Lisinopril—coronary artery disease	0.000116	0.0002	CcSEcCtD
Methylphenidate—Nausea—Clopidogrel—coronary artery disease	0.000116	0.0002	CcSEcCtD
Methylphenidate—Tachycardia—Ramipril—coronary artery disease	0.000116	0.0002	CcSEcCtD
Methylphenidate—Skin disorder—Ramipril—coronary artery disease	0.000115	0.000199	CcSEcCtD
Methylphenidate—Infection—Timolol—coronary artery disease	0.000115	0.000199	CcSEcCtD
Methylphenidate—Vomiting—Simvastatin—coronary artery disease	0.000115	0.000199	CcSEcCtD
Methylphenidate—SLC6A4—Circadian rythm related genes—PPARG—coronary artery disease	0.000115	0.0012	CbGpPWpGaD
Methylphenidate—Hypersensitivity—Telmisartan—coronary artery disease	0.000115	0.000199	CcSEcCtD
Methylphenidate—Cough—Lisinopril—coronary artery disease	0.000115	0.000199	CcSEcCtD
Methylphenidate—Nausea—Lovastatin—coronary artery disease	0.000115	0.000199	CcSEcCtD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	0.000115	0.0012	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	0.000115	0.0012	CbGpPWpGaD
Methylphenidate—Hyperhidrosis—Ramipril—coronary artery disease	0.000115	0.000198	CcSEcCtD
Methylphenidate—SLC6A4—Circadian rythm related genes—GSK3B—coronary artery disease	0.000114	0.00119	CbGpPWpGaD
Methylphenidate—Rash—Simvastatin—coronary artery disease	0.000114	0.000197	CcSEcCtD
Methylphenidate—Dermatitis—Simvastatin—coronary artery disease	0.000114	0.000197	CcSEcCtD
Methylphenidate—Asthenia—Trandolapril—coronary artery disease	0.000114	0.000197	CcSEcCtD
Methylphenidate—Shock—Timolol—coronary artery disease	0.000114	0.000197	CcSEcCtD
Methylphenidate—Feeling abnormal—Losartan—coronary artery disease	0.000114	0.000197	CcSEcCtD
Methylphenidate—Urticaria—Furosemide—coronary artery disease	0.000114	0.000197	CcSEcCtD
Methylphenidate—Diarrhoea—Niacin—coronary artery disease	0.000114	0.000197	CcSEcCtD
Methylphenidate—Nervous system disorder—Timolol—coronary artery disease	0.000114	0.000197	CcSEcCtD
Methylphenidate—Asthenia—Enalapril—coronary artery disease	0.000114	0.000196	CcSEcCtD
Methylphenidate—SLC6A4—Circadian rythm related genes—CREB1—coronary artery disease	0.000113	0.00118	CbGpPWpGaD
Methylphenidate—Headache—Simvastatin—coronary artery disease	0.000113	0.000196	CcSEcCtD
Methylphenidate—Body temperature increased—Furosemide—coronary artery disease	0.000113	0.000196	CcSEcCtD
Methylphenidate—Abdominal pain—Furosemide—coronary artery disease	0.000113	0.000196	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Losartan—coronary artery disease	0.000113	0.000196	CcSEcCtD
Methylphenidate—Dizziness—Valsartan—coronary artery disease	0.000113	0.000196	CcSEcCtD
Methylphenidate—Anorexia—Ramipril—coronary artery disease	0.000113	0.000195	CcSEcCtD
Methylphenidate—Nausea—Ezetimibe—coronary artery disease	0.000113	0.000195	CcSEcCtD
Methylphenidate—Skin disorder—Timolol—coronary artery disease	0.000113	0.000195	CcSEcCtD
Methylphenidate—Dizziness—Olmesartan—coronary artery disease	0.000112	0.000195	CcSEcCtD
Methylphenidate—Pruritus—Trandolapril—coronary artery disease	0.000112	0.000194	CcSEcCtD
Methylphenidate—Arthralgia—Lisinopril—coronary artery disease	0.000112	0.000194	CcSEcCtD
Methylphenidate—Chest pain—Lisinopril—coronary artery disease	0.000112	0.000194	CcSEcCtD
Methylphenidate—Myalgia—Lisinopril—coronary artery disease	0.000112	0.000194	CcSEcCtD
Methylphenidate—Hyperhidrosis—Timolol—coronary artery disease	0.000112	0.000194	CcSEcCtD
Methylphenidate—Asthenia—Telmisartan—coronary artery disease	0.000112	0.000194	CcSEcCtD
Methylphenidate—Pruritus—Enalapril—coronary artery disease	0.000112	0.000194	CcSEcCtD
Methylphenidate—Diarrhoea—Pravastatin—coronary artery disease	0.000112	0.000194	CcSEcCtD
Methylphenidate—Anxiety—Lisinopril—coronary artery disease	0.000112	0.000193	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000111	0.000193	CcSEcCtD
Methylphenidate—Discomfort—Lisinopril—coronary artery disease	0.000111	0.000192	CcSEcCtD
Methylphenidate—Anorexia—Timolol—coronary artery disease	0.00011	0.000191	CcSEcCtD
Methylphenidate—Pruritus—Telmisartan—coronary artery disease	0.00011	0.000191	CcSEcCtD
Methylphenidate—Nausea—Eplerenone—coronary artery disease	0.00011	0.000191	CcSEcCtD
Methylphenidate—CYP2D6—Metapathway biotransformation—GPX3—coronary artery disease	0.00011	0.00115	CbGpPWpGaD
Methylphenidate—Dizziness—Niacin—coronary artery disease	0.00011	0.00019	CcSEcCtD
Methylphenidate—Urticaria—Losartan—coronary artery disease	0.00011	0.00019	CcSEcCtD
Methylphenidate—Dry mouth—Lisinopril—coronary artery disease	0.00011	0.00019	CcSEcCtD
Methylphenidate—Abdominal pain—Losartan—coronary artery disease	0.000109	0.000189	CcSEcCtD
Methylphenidate—Body temperature increased—Losartan—coronary artery disease	0.000109	0.000189	CcSEcCtD
Methylphenidate—Asthenia—Captopril—coronary artery disease	0.000109	0.000188	CcSEcCtD
Methylphenidate—Diarrhoea—Trandolapril—coronary artery disease	0.000109	0.000188	CcSEcCtD
Methylphenidate—Vomiting—Valsartan—coronary artery disease	0.000109	0.000188	CcSEcCtD
Methylphenidate—Confusional state—Lisinopril—coronary artery disease	0.000108	0.000187	CcSEcCtD
Methylphenidate—Diarrhoea—Enalapril—coronary artery disease	0.000108	0.000187	CcSEcCtD
Methylphenidate—Dizziness—Pravastatin—coronary artery disease	0.000108	0.000187	CcSEcCtD
Methylphenidate—Vomiting—Olmesartan—coronary artery disease	0.000108	0.000187	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000108	0.000187	CcSEcCtD
Methylphenidate—Rash—Valsartan—coronary artery disease	0.000108	0.000186	CcSEcCtD
Methylphenidate—Dermatitis—Valsartan—coronary artery disease	0.000108	0.000186	CcSEcCtD
Methylphenidate—Nausea—Simvastatin—coronary artery disease	0.000107	0.000186	CcSEcCtD
Methylphenidate—Oedema—Lisinopril—coronary artery disease	0.000107	0.000186	CcSEcCtD
Methylphenidate—Anaphylactic shock—Lisinopril—coronary artery disease	0.000107	0.000186	CcSEcCtD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—CXCL8—coronary artery disease	0.000107	0.00112	CbGpPWpGaD
Methylphenidate—Pruritus—Captopril—coronary artery disease	0.000107	0.000186	CcSEcCtD
Methylphenidate—Rash—Olmesartan—coronary artery disease	0.000107	0.000186	CcSEcCtD
Methylphenidate—Insomnia—Ramipril—coronary artery disease	0.000107	0.000185	CcSEcCtD
Methylphenidate—Dermatitis—Olmesartan—coronary artery disease	0.000107	0.000185	CcSEcCtD
Methylphenidate—Headache—Valsartan—coronary artery disease	0.000107	0.000185	CcSEcCtD
Methylphenidate—CYP2D6—Biological oxidations—ALDH2—coronary artery disease	0.000107	0.00111	CbGpPWpGaD
Methylphenidate—Diarrhoea—Telmisartan—coronary artery disease	0.000107	0.000185	CcSEcCtD
Methylphenidate—Infection—Lisinopril—coronary artery disease	0.000107	0.000185	CcSEcCtD
Methylphenidate—Headache—Olmesartan—coronary artery disease	0.000107	0.000184	CcSEcCtD
Methylphenidate—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—coronary artery disease	0.000106	0.00111	CbGpPWpGaD
Methylphenidate—Paraesthesia—Ramipril—coronary artery disease	0.000106	0.000184	CcSEcCtD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	0.000106	0.0011	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—ABCG5—coronary artery disease	0.000106	0.0011	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—HK1—coronary artery disease	0.000106	0.0011	CbGpPWpGaD
Methylphenidate—Shock—Lisinopril—coronary artery disease	0.000106	0.000183	CcSEcCtD
Methylphenidate—Asthenia—Perindopril—coronary artery disease	0.000106	0.000183	CcSEcCtD
Methylphenidate—Dyspnoea—Ramipril—coronary artery disease	0.000106	0.000183	CcSEcCtD
Methylphenidate—Vomiting—Niacin—coronary artery disease	0.000106	0.000183	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000106	0.000183	CcSEcCtD
Methylphenidate—Hypersensitivity—Furosemide—coronary artery disease	0.000106	0.000183	CcSEcCtD
Methylphenidate—Somnolence—Ramipril—coronary artery disease	0.000105	0.000182	CcSEcCtD
Methylphenidate—Thrombocytopenia—Lisinopril—coronary artery disease	0.000105	0.000182	CcSEcCtD
Methylphenidate—Dizziness—Trandolapril—coronary artery disease	0.000105	0.000182	CcSEcCtD
Methylphenidate—Tachycardia—Lisinopril—coronary artery disease	0.000105	0.000181	CcSEcCtD
Methylphenidate—Insomnia—Timolol—coronary artery disease	0.000105	0.000181	CcSEcCtD
Methylphenidate—Rash—Niacin—coronary artery disease	0.000105	0.000181	CcSEcCtD
Methylphenidate—Dermatitis—Niacin—coronary artery disease	0.000105	0.000181	CcSEcCtD
Methylphenidate—Dizziness—Enalapril—coronary artery disease	0.000105	0.000181	CcSEcCtD
Methylphenidate—Skin disorder—Lisinopril—coronary artery disease	0.000104	0.000181	CcSEcCtD
Methylphenidate—CYP2D6—Biological oxidations—CYP2C19—coronary artery disease	0.000104	0.00109	CbGpPWpGaD
Methylphenidate—Dyspepsia—Ramipril—coronary artery disease	0.000104	0.00018	CcSEcCtD
Methylphenidate—Pruritus—Perindopril—coronary artery disease	0.000104	0.00018	CcSEcCtD
Methylphenidate—Headache—Niacin—coronary artery disease	0.000104	0.00018	CcSEcCtD
Methylphenidate—Paraesthesia—Timolol—coronary artery disease	0.000104	0.00018	CcSEcCtD
Methylphenidate—Vomiting—Pravastatin—coronary artery disease	0.000104	0.00018	CcSEcCtD
Methylphenidate—Hyperhidrosis—Lisinopril—coronary artery disease	0.000104	0.00018	CcSEcCtD
Methylphenidate—Diarrhoea—Captopril—coronary artery disease	0.000104	0.00018	CcSEcCtD
Methylphenidate—SLC6A4—Circadian rythm related genes—SERPINE1—coronary artery disease	0.000104	0.00108	CbGpPWpGaD
Methylphenidate—Dyspnoea—Timolol—coronary artery disease	0.000103	0.000179	CcSEcCtD
Methylphenidate—Dizziness—Telmisartan—coronary artery disease	0.000103	0.000179	CcSEcCtD
Methylphenidate—Rash—Pravastatin—coronary artery disease	0.000103	0.000178	CcSEcCtD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL1B—coronary artery disease	0.000103	0.00107	CbGpPWpGaD
Methylphenidate—Dermatitis—Pravastatin—coronary artery disease	0.000103	0.000178	CcSEcCtD
Methylphenidate—Decreased appetite—Ramipril—coronary artery disease	0.000103	0.000178	CcSEcCtD
Methylphenidate—Somnolence—Timolol—coronary artery disease	0.000103	0.000178	CcSEcCtD
Methylphenidate—CYP2D6—Metapathway biotransformation—CYP2C19—coronary artery disease	0.000103	0.00107	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—CASP3—coronary artery disease	0.000103	0.00107	CbGpPWpGaD
Methylphenidate—Asthenia—Furosemide—coronary artery disease	0.000103	0.000178	CcSEcCtD
Methylphenidate—Headache—Pravastatin—coronary artery disease	0.000102	0.000177	CcSEcCtD
Methylphenidate—Anorexia—Lisinopril—coronary artery disease	0.000102	0.000177	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000102	0.000177	CcSEcCtD
Methylphenidate—Fatigue—Ramipril—coronary artery disease	0.000102	0.000177	CcSEcCtD
Methylphenidate—Dyspepsia—Timolol—coronary artery disease	0.000102	0.000176	CcSEcCtD
Methylphenidate—CYP2D6—Biological oxidations—GSTT1—coronary artery disease	0.000102	0.00106	CbGpPWpGaD
Methylphenidate—Hypersensitivity—Losartan—coronary artery disease	0.000102	0.000176	CcSEcCtD
Methylphenidate—Nausea—Valsartan—coronary artery disease	0.000101	0.000176	CcSEcCtD
Methylphenidate—Pruritus—Furosemide—coronary artery disease	0.000101	0.000175	CcSEcCtD
Methylphenidate—Constipation—Ramipril—coronary artery disease	0.000101	0.000175	CcSEcCtD
Methylphenidate—Nausea—Olmesartan—coronary artery disease	0.000101	0.000175	CcSEcCtD
Methylphenidate—Vomiting—Trandolapril—coronary artery disease	0.000101	0.000175	CcSEcCtD
Methylphenidate—Diarrhoea—Perindopril—coronary artery disease	0.000101	0.000174	CcSEcCtD
Methylphenidate—Decreased appetite—Timolol—coronary artery disease	0.000101	0.000174	CcSEcCtD
Methylphenidate—CYP2D6—Biological oxidations—GCLC—coronary artery disease	0.000101	0.00105	CbGpPWpGaD
Methylphenidate—Vomiting—Enalapril—coronary artery disease	0.000101	0.000174	CcSEcCtD
Methylphenidate—Dizziness—Captopril—coronary artery disease	0.0001	0.000174	CcSEcCtD
Methylphenidate—Rash—Trandolapril—coronary artery disease	0.0001	0.000173	CcSEcCtD
Methylphenidate—Dermatitis—Trandolapril—coronary artery disease	0.0001	0.000173	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Timolol—coronary artery disease	0.0001	0.000173	CcSEcCtD
Methylphenidate—Fatigue—Timolol—coronary artery disease	9.99e-05	0.000173	CcSEcCtD
Methylphenidate—Rash—Enalapril—coronary artery disease	9.98e-05	0.000173	CcSEcCtD
Methylphenidate—Dermatitis—Enalapril—coronary artery disease	9.97e-05	0.000172	CcSEcCtD
Methylphenidate—Headache—Trandolapril—coronary artery disease	9.95e-05	0.000172	CcSEcCtD
Methylphenidate—Vomiting—Telmisartan—coronary artery disease	9.92e-05	0.000172	CcSEcCtD
Methylphenidate—Asthenia—Losartan—coronary artery disease	9.91e-05	0.000172	CcSEcCtD
Methylphenidate—Headache—Enalapril—coronary artery disease	9.91e-05	0.000171	CcSEcCtD
Methylphenidate—Pain—Timolol—coronary artery disease	9.91e-05	0.000171	CcSEcCtD
Methylphenidate—Nausea—Niacin—coronary artery disease	9.87e-05	0.000171	CcSEcCtD
Methylphenidate—Rash—Telmisartan—coronary artery disease	9.84e-05	0.00017	CcSEcCtD
Methylphenidate—Dermatitis—Telmisartan—coronary artery disease	9.83e-05	0.00017	CcSEcCtD
Methylphenidate—Diarrhoea—Furosemide—coronary artery disease	9.8e-05	0.00017	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Lisinopril—coronary artery disease	9.79e-05	0.000169	CcSEcCtD
Methylphenidate—Pruritus—Losartan—coronary artery disease	9.78e-05	0.000169	CcSEcCtD
Methylphenidate—Headache—Telmisartan—coronary artery disease	9.78e-05	0.000169	CcSEcCtD
Methylphenidate—Feeling abnormal—Ramipril—coronary artery disease	9.76e-05	0.000169	CcSEcCtD
Methylphenidate—Dizziness—Perindopril—coronary artery disease	9.74e-05	0.000169	CcSEcCtD
Methylphenidate—Insomnia—Lisinopril—coronary artery disease	9.72e-05	0.000168	CcSEcCtD
Methylphenidate—Nausea—Pravastatin—coronary artery disease	9.72e-05	0.000168	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Ramipril—coronary artery disease	9.69e-05	0.000168	CcSEcCtD
Methylphenidate—Paraesthesia—Lisinopril—coronary artery disease	9.65e-05	0.000167	CcSEcCtD
Methylphenidate—Vomiting—Captopril—coronary artery disease	9.65e-05	0.000167	CcSEcCtD
Methylphenidate—Dyspnoea—Lisinopril—coronary artery disease	9.58e-05	0.000166	CcSEcCtD
Methylphenidate—Rash—Captopril—coronary artery disease	9.57e-05	0.000166	CcSEcCtD
Methylphenidate—Dermatitis—Captopril—coronary artery disease	9.56e-05	0.000165	CcSEcCtD
Methylphenidate—Somnolence—Lisinopril—coronary artery disease	9.55e-05	0.000165	CcSEcCtD
Methylphenidate—Feeling abnormal—Timolol—coronary artery disease	9.55e-05	0.000165	CcSEcCtD
Methylphenidate—Headache—Captopril—coronary artery disease	9.51e-05	0.000164	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Timolol—coronary artery disease	9.47e-05	0.000164	CcSEcCtD
Methylphenidate—Dizziness—Furosemide—coronary artery disease	9.47e-05	0.000164	CcSEcCtD
Methylphenidate—Dyspepsia—Lisinopril—coronary artery disease	9.46e-05	0.000164	CcSEcCtD
Methylphenidate—Diarrhoea—Losartan—coronary artery disease	9.46e-05	0.000164	CcSEcCtD
Methylphenidate—Nausea—Trandolapril—coronary artery disease	9.44e-05	0.000163	CcSEcCtD
Methylphenidate—Urticaria—Ramipril—coronary artery disease	9.41e-05	0.000163	CcSEcCtD
Methylphenidate—Nausea—Enalapril—coronary artery disease	9.4e-05	0.000163	CcSEcCtD
Methylphenidate—Vomiting—Perindopril—coronary artery disease	9.37e-05	0.000162	CcSEcCtD
Methylphenidate—Abdominal pain—Ramipril—coronary artery disease	9.37e-05	0.000162	CcSEcCtD
Methylphenidate—Body temperature increased—Ramipril—coronary artery disease	9.37e-05	0.000162	CcSEcCtD
Methylphenidate—Decreased appetite—Lisinopril—coronary artery disease	9.34e-05	0.000162	CcSEcCtD
Methylphenidate—Rash—Perindopril—coronary artery disease	9.29e-05	0.000161	CcSEcCtD
Methylphenidate—Dermatitis—Perindopril—coronary artery disease	9.28e-05	0.000161	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Lisinopril—coronary artery disease	9.28e-05	0.000161	CcSEcCtD
Methylphenidate—Nausea—Telmisartan—coronary artery disease	9.27e-05	0.00016	CcSEcCtD
Methylphenidate—Fatigue—Lisinopril—coronary artery disease	9.26e-05	0.00016	CcSEcCtD
Methylphenidate—Headache—Perindopril—coronary artery disease	9.23e-05	0.00016	CcSEcCtD
Methylphenidate—Urticaria—Timolol—coronary artery disease	9.2e-05	0.000159	CcSEcCtD
Methylphenidate—Pain—Lisinopril—coronary artery disease	9.19e-05	0.000159	CcSEcCtD
Methylphenidate—Constipation—Lisinopril—coronary artery disease	9.19e-05	0.000159	CcSEcCtD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	9.18e-05	0.000955	CbGpPWpGaD
Methylphenidate—Abdominal pain—Timolol—coronary artery disease	9.16e-05	0.000158	CcSEcCtD
Methylphenidate—Body temperature increased—Timolol—coronary artery disease	9.16e-05	0.000158	CcSEcCtD
Methylphenidate—Dizziness—Losartan—coronary artery disease	9.14e-05	0.000158	CcSEcCtD
Methylphenidate—Vomiting—Furosemide—coronary artery disease	9.11e-05	0.000158	CcSEcCtD
Methylphenidate—Rash—Furosemide—coronary artery disease	9.03e-05	0.000156	CcSEcCtD
Methylphenidate—Dermatitis—Furosemide—coronary artery disease	9.02e-05	0.000156	CcSEcCtD
Methylphenidate—Nausea—Captopril—coronary artery disease	9.01e-05	0.000156	CcSEcCtD
Methylphenidate—Headache—Furosemide—coronary artery disease	8.97e-05	0.000155	CcSEcCtD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	8.96e-05	0.000933	CbGpPWpGaD
Methylphenidate—Feeling abnormal—Lisinopril—coronary artery disease	8.86e-05	0.000153	CcSEcCtD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—CETP—coronary artery disease	8.86e-05	0.000922	CbGpPWpGaD
Methylphenidate—Gastrointestinal pain—Lisinopril—coronary artery disease	8.79e-05	0.000152	CcSEcCtD
Methylphenidate—Vomiting—Losartan—coronary artery disease	8.79e-05	0.000152	CcSEcCtD
Methylphenidate—Nausea—Perindopril—coronary artery disease	8.75e-05	0.000151	CcSEcCtD
Methylphenidate—Hypersensitivity—Ramipril—coronary artery disease	8.73e-05	0.000151	CcSEcCtD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—VEGFA—coronary artery disease	8.73e-05	0.000908	CbGpPWpGaD
Methylphenidate—Rash—Losartan—coronary artery disease	8.71e-05	0.000151	CcSEcCtD
Methylphenidate—Dermatitis—Losartan—coronary artery disease	8.71e-05	0.000151	CcSEcCtD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—CREB1—coronary artery disease	8.67e-05	0.000903	CbGpPWpGaD
Methylphenidate—Headache—Losartan—coronary artery disease	8.66e-05	0.00015	CcSEcCtD
Methylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—POMC—coronary artery disease	8.63e-05	0.000898	CbGpPWpGaD
Methylphenidate—Urticaria—Lisinopril—coronary artery disease	8.54e-05	0.000148	CcSEcCtD
Methylphenidate—Hypersensitivity—Timolol—coronary artery disease	8.53e-05	0.000148	CcSEcCtD
Methylphenidate—Nausea—Furosemide—coronary artery disease	8.51e-05	0.000147	CcSEcCtD
Methylphenidate—Asthenia—Ramipril—coronary artery disease	8.5e-05	0.000147	CcSEcCtD
Methylphenidate—Body temperature increased—Lisinopril—coronary artery disease	8.5e-05	0.000147	CcSEcCtD
Methylphenidate—Abdominal pain—Lisinopril—coronary artery disease	8.5e-05	0.000147	CcSEcCtD
Methylphenidate—SLC6A4—NRF2 pathway—TGFB1—coronary artery disease	8.45e-05	0.000879	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—TFRC—coronary artery disease	8.39e-05	0.000874	CbGpPWpGaD
Methylphenidate—Pruritus—Ramipril—coronary artery disease	8.38e-05	0.000145	CcSEcCtD
Methylphenidate—Asthenia—Timolol—coronary artery disease	8.31e-05	0.000144	CcSEcCtD
Methylphenidate—Nausea—Losartan—coronary artery disease	8.21e-05	0.000142	CcSEcCtD
Methylphenidate—Pruritus—Timolol—coronary artery disease	8.2e-05	0.000142	CcSEcCtD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	8.13e-05	0.000846	CbGpPWpGaD
Methylphenidate—Diarrhoea—Ramipril—coronary artery disease	8.11e-05	0.00014	CcSEcCtD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	7.94e-05	0.000826	CbGpPWpGaD
Methylphenidate—Diarrhoea—Timolol—coronary artery disease	7.93e-05	0.000137	CcSEcCtD
Methylphenidate—Hypersensitivity—Lisinopril—coronary artery disease	7.92e-05	0.000137	CcSEcCtD
Methylphenidate—CYP2D6—Biological oxidations—GGT1—coronary artery disease	7.86e-05	0.000818	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—CETP—coronary artery disease	7.84e-05	0.000817	CbGpPWpGaD
Methylphenidate—Dizziness—Ramipril—coronary artery disease	7.84e-05	0.000136	CcSEcCtD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—PLAT—coronary artery disease	7.8e-05	0.000812	CbGpPWpGaD
Methylphenidate—Asthenia—Lisinopril—coronary artery disease	7.71e-05	0.000133	CcSEcCtD
Methylphenidate—Dizziness—Timolol—coronary artery disease	7.66e-05	0.000133	CcSEcCtD
Methylphenidate—Pruritus—Lisinopril—coronary artery disease	7.6e-05	0.000132	CcSEcCtD
Methylphenidate—Vomiting—Ramipril—coronary artery disease	7.53e-05	0.00013	CcSEcCtD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—TNF—coronary artery disease	7.48e-05	0.000778	CbGpPWpGaD
Methylphenidate—Rash—Ramipril—coronary artery disease	7.47e-05	0.000129	CcSEcCtD
Methylphenidate—Dermatitis—Ramipril—coronary artery disease	7.46e-05	0.000129	CcSEcCtD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—TFRC—coronary artery disease	7.44e-05	0.000774	CbGpPWpGaD
Methylphenidate—Headache—Ramipril—coronary artery disease	7.42e-05	0.000128	CcSEcCtD
Methylphenidate—Vomiting—Timolol—coronary artery disease	7.37e-05	0.000127	CcSEcCtD
Methylphenidate—Diarrhoea—Lisinopril—coronary artery disease	7.35e-05	0.000127	CcSEcCtD
Methylphenidate—Rash—Timolol—coronary artery disease	7.3e-05	0.000126	CcSEcCtD
Methylphenidate—Dermatitis—Timolol—coronary artery disease	7.3e-05	0.000126	CcSEcCtD
Methylphenidate—SLC6A2—NRF2 pathway—TGFB1—coronary artery disease	7.26e-05	0.000756	CbGpPWpGaD
Methylphenidate—Headache—Timolol—coronary artery disease	7.26e-05	0.000126	CcSEcCtD
Methylphenidate—SLC6A2—SLC-mediated transmembrane transport—ALB—coronary artery disease	7.24e-05	0.000753	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CA5B—coronary artery disease	7.14e-05	0.000743	CbGpPWpGaD
Methylphenidate—Dizziness—Lisinopril—coronary artery disease	7.11e-05	0.000123	CcSEcCtD
Methylphenidate—CYP2D6—Biological oxidations—GSTP1—coronary artery disease	7.06e-05	0.000735	CbGpPWpGaD
Methylphenidate—Nausea—Ramipril—coronary artery disease	7.04e-05	0.000122	CcSEcCtD
Methylphenidate—CYP2D6—Metapathway biotransformation—GSTP1—coronary artery disease	6.96e-05	0.000724	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—PLAT—coronary artery disease	6.91e-05	0.00072	CbGpPWpGaD
Methylphenidate—Nausea—Timolol—coronary artery disease	6.88e-05	0.000119	CcSEcCtD
Methylphenidate—Vomiting—Lisinopril—coronary artery disease	6.83e-05	0.000118	CcSEcCtD
Methylphenidate—Rash—Lisinopril—coronary artery disease	6.78e-05	0.000117	CcSEcCtD
Methylphenidate—Dermatitis—Lisinopril—coronary artery disease	6.77e-05	0.000117	CcSEcCtD
Methylphenidate—Headache—Lisinopril—coronary artery disease	6.73e-05	0.000116	CcSEcCtD
Methylphenidate—SLC6A3—Neuronal System—CREB1—coronary artery disease	6.65e-05	0.000692	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—PLG—coronary artery disease	6.64e-05	0.000691	CbGpPWpGaD
Methylphenidate—CYP2D6—Biological oxidations—GSTM1—coronary artery disease	6.49e-05	0.000675	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—TGFB1—coronary artery disease	6.43e-05	0.00067	CbGpPWpGaD
Methylphenidate—SLC6A3—SLC-mediated transmembrane transport—ALB—coronary artery disease	6.41e-05	0.000667	CbGpPWpGaD
Methylphenidate—CYP2D6—Metapathway biotransformation—GSTM1—coronary artery disease	6.4e-05	0.000666	CbGpPWpGaD
Methylphenidate—Nausea—Lisinopril—coronary artery disease	6.38e-05	0.00011	CcSEcCtD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—HMOX1—coronary artery disease	6.12e-05	0.000637	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CKMT1B—coronary artery disease	6.07e-05	0.000632	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL6—coronary artery disease	6.04e-05	0.000628	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—PLG—coronary artery disease	5.88e-05	0.000612	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—APOB—coronary artery disease	5.87e-05	0.000611	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—HMOX1—coronary artery disease	5.43e-05	0.000565	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—APOB—coronary artery disease	5.2e-05	0.000541	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PPAP2B—coronary artery disease	4.95e-05	0.000515	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CKM—coronary artery disease	4.95e-05	0.000515	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—UQCRFS1—coronary artery disease	4.95e-05	0.000515	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—IL6—coronary artery disease	4.93e-05	0.000513	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—MAPK1—coronary artery disease	4.9e-05	0.000511	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—APOA1—coronary artery disease	4.64e-05	0.000483	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CKMT2—coronary artery disease	4.6e-05	0.000479	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PDK4—coronary artery disease	4.6e-05	0.000479	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PYGM—coronary artery disease	4.6e-05	0.000479	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—SULT4A1—coronary artery disease	4.6e-05	0.000479	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ALDH6A1—coronary artery disease	4.6e-05	0.000479	CbGpPWpGaD
Methylphenidate—CYP2D6—Biological oxidations—POMC—coronary artery disease	4.58e-05	0.000477	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—APOA1—coronary artery disease	4.11e-05	0.000428	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GK—coronary artery disease	4.1e-05	0.000427	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GYG1—coronary artery disease	4.1e-05	0.000427	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—LDHA—coronary artery disease	4.1e-05	0.000427	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PFKM—coronary artery disease	4.1e-05	0.000427	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—HMGCS2—coronary artery disease	4.1e-05	0.000427	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GATM—coronary artery disease	4.1e-05	0.000427	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—AK1—coronary artery disease	3.91e-05	0.000407	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GCH1—coronary artery disease	3.91e-05	0.000407	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—MAPK1—coronary artery disease	3.76e-05	0.000391	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PLCD1—coronary artery disease	3.75e-05	0.00039	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—UGCG—coronary artery disease	3.75e-05	0.00039	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PPAT—coronary artery disease	3.75e-05	0.00039	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—MDH2—coronary artery disease	3.75e-05	0.00039	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—ALB—coronary artery disease	3.68e-05	0.000383	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PGM1—coronary artery disease	3.61e-05	0.000376	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CKB—coronary artery disease	3.48e-05	0.000363	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PYGB—coronary artery disease	3.48e-05	0.000363	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PLIN1—coronary artery disease	3.28e-05	0.000341	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GSTM2—coronary artery disease	3.28e-05	0.000341	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—DLAT—coronary artery disease	3.28e-05	0.000341	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PFKFB3—coronary artery disease	3.28e-05	0.000341	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—COX5B—coronary artery disease	3.28e-05	0.000341	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—ALB—coronary artery disease	3.26e-05	0.000339	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—SULT1E1—coronary artery disease	3.11e-05	0.000323	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—AKR1B1—coronary artery disease	2.96e-05	0.000308	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—HK2—coronary artery disease	2.96e-05	0.000308	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—SLC27A1—coronary artery disease	2.84e-05	0.000296	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—LCAT—coronary artery disease	2.79e-05	0.00029	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CPT1B—coronary artery disease	2.79e-05	0.00029	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—APOA4—coronary artery disease	2.73e-05	0.000285	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PDHA1—coronary artery disease	2.64e-05	0.000275	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GCLM—coronary artery disease	2.64e-05	0.000275	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CYP11B2—coronary artery disease	2.56e-05	0.000266	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—TXNRD1—coronary artery disease	2.56e-05	0.000266	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—SLC22A3—coronary artery disease	2.52e-05	0.000262	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—HADH—coronary artery disease	2.48e-05	0.000258	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ARNTL—coronary artery disease	2.48e-05	0.000258	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GPX2—coronary artery disease	2.35e-05	0.000245	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—APOA2—coronary artery disease	2.35e-05	0.000245	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PLA2G2A—coronary artery disease	2.35e-05	0.000245	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ABCG5—coronary artery disease	2.33e-05	0.000242	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—HK1—coronary artery disease	2.33e-05	0.000242	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GPX4—coronary artery disease	2.33e-05	0.000242	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—SULT1A1—coronary artery disease	2.33e-05	0.000242	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—HADHA—coronary artery disease	2.3e-05	0.000239	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GSTA1—coronary artery disease	2.27e-05	0.000236	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—LPA—coronary artery disease	2.25e-05	0.000234	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PLCB3—coronary artery disease	2.17e-05	0.000226	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—APOA5—coronary artery disease	2.15e-05	0.000224	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—P4HB—coronary artery disease	2.11e-05	0.00022	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PLA2G1B—coronary artery disease	2.07e-05	0.000216	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—VCAN—coronary artery disease	1.95e-05	0.000203	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ALDOA—coronary artery disease	1.94e-05	0.000202	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—DCN—coronary artery disease	1.88e-05	0.000196	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ALDH2—coronary artery disease	1.83e-05	0.000191	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	1.78e-05	0.000186	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CYP2C19—coronary artery disease	1.78e-05	0.000186	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—LIPC—coronary artery disease	1.78e-05	0.000186	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—HBA1—coronary artery disease	1.78e-05	0.000186	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—APOC3—coronary artery disease	1.77e-05	0.000185	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—LDLR—coronary artery disease	1.76e-05	0.000183	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—SLC9A1—coronary artery disease	1.74e-05	0.000181	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GSTT1—coronary artery disease	1.74e-05	0.000181	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CETP—coronary artery disease	1.72e-05	0.000179	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GCLC—coronary artery disease	1.72e-05	0.000179	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—SDC1—coronary artery disease	1.7e-05	0.000177	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PSMB5—coronary artery disease	1.61e-05	0.000167	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PSMA6—coronary artery disease	1.61e-05	0.000167	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CTGF—coronary artery disease	1.57e-05	0.000163	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—HMGCR—coronary artery disease	1.56e-05	0.000162	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GOT2—coronary artery disease	1.56e-05	0.000162	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PLCB1—coronary artery disease	1.43e-05	0.000149	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ABCA1—coronary artery disease	1.39e-05	0.000144	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GGT1—coronary artery disease	1.34e-05	0.00014	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GOT1—coronary artery disease	1.34e-05	0.00014	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GSTP1—coronary artery disease	1.21e-05	0.000126	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	1.2e-05	0.000124	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—HMOX1—coronary artery disease	1.19e-05	0.000124	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CAT—coronary artery disease	1.17e-05	0.000122	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—APOB—coronary artery disease	1.14e-05	0.000119	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GSTM1—coronary artery disease	1.11e-05	0.000115	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—LPL—coronary artery disease	1.09e-05	0.000113	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GPX1—coronary artery disease	1.06e-05	0.000111	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CD36—coronary artery disease	1.03e-05	0.000108	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PPP2CA—coronary artery disease	1.02e-05	0.000106	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—MTHFR—coronary artery disease	9.8e-06	0.000102	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—AGT—coronary artery disease	9.31e-06	9.69e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—APOE—coronary artery disease	9.13e-06	9.5e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—APOA1—coronary artery disease	9.02e-06	9.39e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PPARG—coronary artery disease	7.95e-06	8.27e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—POMC—coronary artery disease	7.84e-06	8.16e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ALB—coronary artery disease	7.15e-06	7.44e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—NOS3—coronary artery disease	6.84e-06	7.12e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PTGS2—coronary artery disease	6.25e-06	6.51e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PIK3CA—coronary artery disease	3.85e-06	4e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—AKT1—coronary artery disease	3.14e-06	3.27e-05	CbGpPWpGaD
